ID

25055

Descrizione

Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Study conclusion.

Keywords

  1. 25/08/17 25/08/17 -
  2. 08/09/17 08/09/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

25 agosto 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

General information
Descrizione

General information

Protocol identifier
Descrizione

Protocol identifier

Tipo di dati

text

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Visit Description
Descrizione

Visit Description

Tipo di dati

text

Pregnancy information
Descrizione

Pregnancy information

Did the subject become pregnant during the study?
Descrizione

If Yes, complete Pregnancy Notification form.

Tipo di dati

text

Study conclusion
Descrizione

Study conclusion

Date of subject completion or withdrawal
Descrizione

Date

Tipo di dati

date

Was the subject withdrawn from the study?
Descrizione

Withdrawal

Tipo di dati

boolean

If Yes, check the primary reason for withdrawal:
Descrizione

reason withdrawal

Tipo di dati

text

If other reason, specify
Descrizione

other reason withdrawal

Tipo di dati

text

Investigator comment log
Descrizione

Investigator comment log

CRF page number if applicable
Descrizione

CRF page number

Tipo di dati

integer

Comment
Descrizione

Comment

Tipo di dati

text

Investigator's signature
Descrizione

Investigator's signature

Investigator’s Signature
Descrizione

Investigator Signature

Tipo di dati

text

Date
Descrizione

signature date

Tipo di dati

date

Investigator’s name (print)
Descrizione

Investigator name

Tipo di dati

text

Similar models

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General information
Protocol identifier
Item
Protocol identifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Description
Item
Visit Description
text
Item Group
Pregnancy information
Item
Did the subject become pregnant during the study?
text
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not Applicable (not of childbearing potential or male) (x)
Item Group
Study conclusion
Date
Item
Date of subject completion or withdrawal
date
Withdrawal
Item
Was the subject withdrawn from the study?
boolean
Item
If Yes, check the primary reason for withdrawal:
text
Code List
If Yes, check the primary reason for withdrawal:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Dyskinesia (28)
CL Item
Other (Z)
other reason withdrawal
Item
If other reason, specify
text
Item Group
Investigator comment log
CRF page number
Item
CRF page number if applicable
integer
Comment
Item
Comment
text
Item Group
Investigator's signature
Investigator Signature
Item
Investigator’s Signature
text
signature date
Item
Date
date
Investigator name
Item
Investigator’s name (print)
text

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial